HealthMap

Copper Antagonism in the Gastrointestinal Tract

According to Dr. Ronald Roth (acu-cell.com), Zinc is the primary copper antagonist that acts predominantly within the gastrointestinal tract.

Mechanism of Action

• Mucosal Blockade: Oral zinc supplementation induces the synthesis of metallothionein in the intestinal mucosal cells.
• Binding Affinity: Metallothionein has a higher binding affinity for copper than for zinc.
• Fecal Excretion: Once copper is bound to metallothionein within the gut wall, it becomes trapped and is subsequently eliminated from the body via the feces when the mucosal cells are naturally shed.

Clinical Application

• This local GI interaction makes zinc therapy a primary approach for reducing excess copper absorption without necessarily altering systemic tissue levels as aggressively as chelating agents.
• Caution: Because zinc and copper exist in a delicate nutritional balance, long-term or high-dose zinc supplementation must be carefully monitored to avoid inducing an unintended copper deficiency.